Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells

Our results suggest it may be possible to combine progestins and NSAIDs to achieve ovarian cancer prevention at lower doses of each than are required for single administration, thereby lessening the risk of side effects posed by these agents.